Researchers conducted a meta-analysis to investigate the potential relationship between screen usage and autism spectrum disorders (ASD).
FDA hands down approval for Bristol Myers’ lung cancer drug from Turning Point buyout
Bristol Myers Squibb’s $4.1 billion buyout of Turning Point Therapeutics has paid off, with the FDA handing down an approval of the lead cancer drug